{"disease":{"id":"fluorescein-angiography-imaging","name":"fluorescein angiography imaging"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04201340","title":"Topcon DRI OCT Triton With SS-OCT Angio Software Evaluation Study","phase":"","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"Topcon Corporation","has_results":false},{"nct_id":"NCT04701931","title":"OCT Angiography Software Evaluation Study","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Topcon Corporation","has_results":false},{"nct_id":"NCT03107104","title":"Triton Fundus Autofluorescence and Fluorescein Angiography","phase":"","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Topcon Medical Systems, Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}